These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

695 related items for PubMed ID: 30287079

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Donor's APOL1 Risk Genotype and "Second Hits" Associated With De Novo Collapsing Glomerulopathy in Deceased Donor Kidney Transplant Recipients: A Report of 5 Cases.
    Chang JH, Husain SA, Santoriello D, Stokes MB, Miles CD, Foster KW, Li Y, Dale LA, Crew RJ, Cohen DJ, Kiryluk K, Gharavi AG, Mohan S.
    Am J Kidney Dis; 2019 Jan; 73(1):134-139. PubMed ID: 30054024
    [Abstract] [Full Text] [Related]

  • 3. Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants.
    Swaminathan S, Lager DJ, Qian X, Stegall MD, Larson TS, Griffin MD.
    Nephrol Dial Transplant; 2006 Sep; 21(9):2607-14. PubMed ID: 16705026
    [Abstract] [Full Text] [Related]

  • 4. APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.
    Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND, Palanisamy A, Reeves-Daniel AM, Brown WM, Divers J.
    Transplantation; 2016 Jan; 100(1):194-202. PubMed ID: 26566060
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Recipient APOL1 risk alleles associate with death-censored renal allograft survival and rejection episodes.
    Zhang Z, Sun Z, Fu J, Lin Q, Banu K, Chauhan K, Planoutene M, Wei C, Salem F, Yi Z, Liu R, Cravedi P, Cheng H, Hao K, O'Connell PJ, Ishibe S, Zhang W, Coca SG, Gibson IW, Colvin RB, He JC, Heeger PS, Murphy B, Menon MC.
    J Clin Invest; 2021 Nov 15; 131(22):. PubMed ID: 34499625
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of Replacing Race With Apolipoprotein L1 Genotype in Calculation of Kidney Donor Risk Index.
    Julian BA, Gaston RS, Brown WM, Reeves-Daniel AM, Israni AK, Schladt DP, Pastan SO, Mohan S, Freedman BI, Divers J.
    Am J Transplant; 2017 Jun 15; 17(6):1540-1548. PubMed ID: 27862962
    [Abstract] [Full Text] [Related]

  • 9. Expanding the spectrum of APOL1-related renal disease: de novo collapsing glomerulopathy following kidney transplant.
    Kopp JB.
    Kidney Int; 2018 Dec 15; 94(6):1048-1050. PubMed ID: 30466562
    [Abstract] [Full Text] [Related]

  • 10. Zonal distribution of glomerular collapse in renal allografts: possible role of vascular changes.
    Nadasdy T, Allen C, Zand MS.
    Hum Pathol; 2002 Apr 15; 33(4):437-41. PubMed ID: 12055680
    [Abstract] [Full Text] [Related]

  • 11. De Novo Focal and Segmental Glomerulosclerosis After COVID-19 in a Patient With a Transplanted Kidney From a Donor With a High-risk APOL1 Variant.
    Oniszczuk J, Moktefi A, Mausoleo A, Pallet N, Malard-Castagnet S, Fourati S, El Karoui K, Sahali D, Stehlé T, Boueilh A, Verpont MC, Matignon M, Buob D, Grimbert P, Audard V.
    Transplantation; 2021 Jan 01; 105(1):206-211. PubMed ID: 32852403
    [Abstract] [Full Text] [Related]

  • 12. Focal segmental glomerulosclerosis in renal allografts with chronic nephropathy: implications for graft survival.
    Cosio FG, Frankel WL, Pelletier RP, Pesavento TE, Henry ML, Ferguson RM.
    Am J Kidney Dis; 1999 Oct 01; 34(4):731-8. PubMed ID: 10516356
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL 1 High-Risk Genotype.
    Wu H, Larsen CP, Hernandez-Arroyo CF, Mohamed MMB, Caza T, Sharshir M, Chughtai A, Xie L, Gimenez JM, Sandow TA, Lusco MA, Yang H, Acheampong E, Rosales IA, Colvin RB, Fogo AB, Velez JCQ.
    J Am Soc Nephrol; 2020 Aug 01; 31(8):1688-1695. PubMed ID: 32561682
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.